Skip to main content
Clinical Trials/2022-501804-80-00
2022-501804-80-00
Completed
Phase 1

A study investigating the pain-relieving effects of a new drug in healthy adults

Trevena Inc.1 site in 1 country24 target enrollmentStarted: November 15, 2022Last updated:

Overview

Phase
Phase 1
Status
Completed
Enrollment
24
Locations
1

Overview

Brief Summary

No summary available.

Eligibility Criteria

Ages
18 years to 64 years (18-64 Years)
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor Class
Pharmaceutical company
Responsible Party
Principal Investigator
Principal Investigator

CHDR

Scientific

Trevena Inc.

Study Sites (1)

Loading locations...

Similar Trials